trending Market Intelligence /marketintelligence/en/news-insights/trending/D9PCQmJ8sxgfTYD-Cb-duA2 content esgSubNav
In This List

Bristol-Myers Squibb names CEO to chairman post

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Bristol-Myers Squibb names CEO to chairman post

Bristol-Myers Squibb Co.'s board appointed CEO Giovanni Caforio as chairman, effective May 2, 2017.

Caforio will retain his position as CEO. He succeeds current Chairman Lamberto Andreotti, who plans to retire.

Andreotti will have served as chairman for two years when Caforio's appointment becomes effective. Caforio has been CEO since May 2015 and has been serving on the board since June 2014.